Φορτώνει......
Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
TKI therapy has shown excellent efficacy and favorable tolerability in patients with mutation-positive nonsmall cell lung cancer. However, there is no clear consensus on the role of TKI as induction therapy. In this article, we reviewed recently published studies to analyze the benefits of tyrosine...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Opin Oncol |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Lippincott Williams & Wilkins
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752212/ https://ncbi.nlm.nih.gov/pubmed/33165003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000696 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|